Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M S Sands

Showing results (11-20 of 43) with videos related to

Pageof 5
Sort By:
Molecular Therapy : the Journal of the American Society of Gene Therapy|September 14, 2000
Delivery of a retroviral vector expressing human beta-glucuronidase to the liver and spleen decreases lysosomal storage in mucopolysaccharidosis VII miceC Gao, M S Sands, M E Haskins, et al.
Bone|February 22, 2002
Abnormal osteoclast morphology and bone remodeling in a murine model of a lysosomal storage diseaseM A Monroy, F P Ross, S L Teitelbaum, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 3, 1999
Neonatal gene transfer leads to widespread correction of pathology in a murine model of lysosomal storage diseaseT M Daly, C Vogler, B Levy, et al.
Experimental Eye Research|October 21, 2000
Retinal function is improved in a murine model of a lysosomal storage disease following bone marrow transplantationK K Ohlemiller, C A Vogler, M Roberts, et al.
AJNR. American Journal of Neuroradiology|July 1, 1984
Iohexol lumbar myelography: clinical studyJ C Holder, E F Binet, D K Kido, et al.
Pediatric and Developmental Pathology : the Official Journal of the Society for Pediatric Pathology and the Paediatric Pathology Society|January 10, 2002
Murine mucopolysaccharidosis VIL: impact of therapies on the phenotype, clinical course, and pathology in a model of a lysosomal storage diseaseC Vogler, J Barker, M S Sands, et al.
Human Gene Therapy|October 25, 2000
Treatment of a lysosomal storage disease, mucopolysaccharidosis VII, with microencapsulated recombinant cellsC J Ross, L Bastedo, S A Maier, et al.
Blood|September 1, 1995
Syngeneic bone marrow transplantation reduces the hearing loss associated with murine mucopolysaccharidosis type VIIM S Sands, L C Erway, C Vogler, et al.
Human Gene Therapy|February 18, 1999
Neonatal intramuscular injection with recombinant adeno-associated virus results in prolonged beta-glucuronidase expression in situ and correction of liver pathology in mucopolysaccharidosis type VII miceT M Daly, T Okuyama, C Vogler, et al.
Neuropathology and Applied Neurobiology|August 26, 2020
Spinal manifestations of CLN1 disease start during the early postnatal periodH R Nelvagal, J T Dearborn, J R Ostergaard, et al.
Pageof 5

Showing results (11-20 of 43) with videos related to

Sort By:
Pageof 5
Molecular Therapy : the Journal of the American Society of Gene Therapy|September 14, 2000
Delivery of a retroviral vector expressing human beta-glucuronidase to the liver and spleen decreases lysosomal storage in mucopolysaccharidosis VII miceC Gao, M S Sands, M E Haskins, et al.
Bone|February 22, 2002
Abnormal osteoclast morphology and bone remodeling in a murine model of a lysosomal storage diseaseM A Monroy, F P Ross, S L Teitelbaum, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 3, 1999
Neonatal gene transfer leads to widespread correction of pathology in a murine model of lysosomal storage diseaseT M Daly, C Vogler, B Levy, et al.
Experimental Eye Research|October 21, 2000
Retinal function is improved in a murine model of a lysosomal storage disease following bone marrow transplantationK K Ohlemiller, C A Vogler, M Roberts, et al.
AJNR. American Journal of Neuroradiology|July 1, 1984
Iohexol lumbar myelography: clinical studyJ C Holder, E F Binet, D K Kido, et al.
Pediatric and Developmental Pathology : the Official Journal of the Society for Pediatric Pathology and the Paediatric Pathology Society|January 10, 2002
Murine mucopolysaccharidosis VIL: impact of therapies on the phenotype, clinical course, and pathology in a model of a lysosomal storage diseaseC Vogler, J Barker, M S Sands, et al.
Human Gene Therapy|October 25, 2000
Treatment of a lysosomal storage disease, mucopolysaccharidosis VII, with microencapsulated recombinant cellsC J Ross, L Bastedo, S A Maier, et al.
Blood|September 1, 1995
Syngeneic bone marrow transplantation reduces the hearing loss associated with murine mucopolysaccharidosis type VIIM S Sands, L C Erway, C Vogler, et al.
Human Gene Therapy|February 18, 1999
Neonatal intramuscular injection with recombinant adeno-associated virus results in prolonged beta-glucuronidase expression in situ and correction of liver pathology in mucopolysaccharidosis type VII miceT M Daly, T Okuyama, C Vogler, et al.
Neuropathology and Applied Neurobiology|August 26, 2020
Spinal manifestations of CLN1 disease start during the early postnatal periodH R Nelvagal, J T Dearborn, J R Ostergaard, et al.
Pageof 5